AbstrAct
Levels of prostaglandin E 2 (PGE 2 ) and its processing enzyme, prostaglandin-endoperoxide-synthase-2/ cyclooxygenase-2 (PTGS2/COX-2), are elevated in actively progressing periodontal lesions, but suppressed in chronic disease. COX-2 expression is regulated through inflammatory signaling that converges on the mitogen-activated protein kinase (MAPK) pathway. Emerging evidence suggests a role for the inflammatory adaptor protein, ASC/Pycard, in MAPK activation. We postulated that ASC may represent a mediator of the MAPK-mediated regulatory network of PGE 2 production. Using RNAi-mediated gene silencing, we demonstrated that ASC regulates COX-2 expression and PGE 2 production in THP1 monocytic cells following infection with Porphyromonas gingivalis (Pg) . Production of PGE 2 did not require the inflammasome adaptor function of ASC, but was dependent on MAPK activation. Furthermore, the MAP kinase kinase kinase CARD domain-containing protein RIPK2 was induced by Pg in an ASCdependent manner. Reduced ASC and RIPK2 levels were revealed by orthogonal comparison of the expression of the RIPK family in ASC-deficient THP1 cells with that in chronic periodontitis patients. We show that pharmacological inhibition of RIPK2 represses PGE 2 secretion, and RNAi-mediated silencing of RIPK2 leads to diminished MAPK activation and PGE 2 secretion. These findings identify a novel ASC-RIPK2 axis in the generation of PGE 2 that is repressed in patients diagnosed with chronic adult periodontitis.
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IntrODuctIOn
F rom 5 to 20% of the population is affected by severe periodontitis (Petersen et al., 2005) , a condition that is the leading cause of tooth loss in adults and increases risks for several major systemic diseases, including coronary heart disease, atherosclerosis, rheumatoid arthritis, cancer, and preterm birth (Lamster et al., 2008; Hayashi et al., 2010) . In this study, we abided by the 1999 World Workshop for the Classification of Periodontal Diseases and Conditions to define the chronic periodontitis condition (Caton and Armitage, 1999) . The establishment of chronic periodontitis entails multiple cycles of progression and remission mediated by the modulation of pro-inflammatory signaling activities (Demmer and Papapanou, 2010) . Identification of underlying inflammatory mechanisms of periodontal disease holds promise for the development of novel targets of periodontal treatment. One inflammatory mediator that has spanned the interface between bacterial infection and periodontal tissue damage is prostaglandin E 2 (PGE 2 ; Offenbacher et al., 1993; Noguchi and Ishikawa, 2007) . Although the correlation between PGE 2 levels in gingival crevicular fluid (GCF) and clinical parameters of periodontitis such as periodontal attachment loss and signs of bleeding on probing has been documented (Noguchi and Ishikawa, 2007; Zhong et al., 2007; Zhang et al., 2011) , it is critical to interpret the value of PGE 2 levels in periodontitis progression in a stage-sensitive fashion. For example, acute challenge of rat periodontal tissue with lipopolysaccharide (LPS) induces the expression of prostaglandin-endoperoxide synthase-2/cyclooxygenase-2 (PTGS2, or COX-2), which is responsible for the biosynthesis of PGE 2 (Miyauchi et al., 2004) . However, cumulative damage of periodontal tissue is negatively associated with PGE 2 levels in GCF (Zhong et al., 2007) . One possible mechanism for the reduced PGE 2 expression during chronic disease involves epigenetic modification leading to decreased COX-2 mRNA synthesis. Recently, Zhang et al. reported hypermethylation at the COX-2 promoter, which was associated with squelched PGE 2 mRNA expression and lowered PGE 2 production in chronic inflamed tissues (Zhang et al., 2011) . The expression of COX-2 is known to be regulated by extracellular stimuli through a variety of inflammatory signaling pathways that converge on the mitogenactivated protein kinase (MAPK) pathway (Tsatsanis et al., 2006) . However, the molecular machinery that is involved in MAPK-mediated regulation of PGE 2 generation remains poorly defined.
Emerging evidence suggests that ASC (apoptosis-associated speck-like protein containing a CARD), an important mediator of host pro-inflammatory Asc-dependent rIP2 Kinase regulates reduced PGE 2 Production in chronic Periodontitis J Dent Res 91(9) 2012 responses, is pivotal in mediating NF-κB and MAPK signaling, and cytokine and chemokine expression in THP1 monocytic cells following infection with Porphyromonas gingivalis (Pg) (Taxman et al., 2006b (Taxman et al., , 2011 . Pg is a bacterial pathogen that has been unequivocally shown to mediate tissue destruction and trigger host inflammatory responses in chronic periodontitis (Hayashi et al., 2010) . We postulated that PGE 2 production may be regulated through ASC-dependent activation of MAPK. A MAPK pathway regulator that associates with ASC via its CARD (caspase activation and recruit domain), RIPK2, belongs to the RIP family of kinases (Receptor-Interacting serine/threonine-Protein Kinase); (Navas et al., 1999; Sarkar et al., 2006) . The RIPK family acts as integrators of cellular stress responses for a diverse array of stimuli, including pathogenic infection, inflammation, and DNA damage (Meylan and Tschopp, 2005) . We hypothesized that RIPK2 may mediate ASC-dependent MAPK and PGE 2 activation.
MAtErIAls & MEthODs bacterial culture
We used the A7436 strain, because of its established immunostimulatory effect on monocytic cells (Taxman et al., 2006b (Taxman et al., , 2011 Huang et al., 2009) and virulence properties (Genco et al., 1991) . Pg strain A7436 was grown anaerobically in Wilkins-Chalgren broth to late-exponential phase (OD 0.8 to 1.2 at 600 nm). Frozen aliquots were stored in media containing 10% glycerol at -80°C and thawed immediately prior to use. The enumeration and viability of bacteria were verified by serial plating.
cell culture and Generation of Knockdown cell lines THP1 monocytic cells (ATCC, Manassas, VA, USA) were cultured in RPMI, 10% FCS. THP1 cell lines bearing a short hairpin RNA (shRNA) for RNA interference (RNAi)-mediated gene silencing of ASC (shASC#1 and shASC#2) or a control, nonsilencing shRNA (shCTRL) were generated with retroviral vectors and have been described previously (Taxman et al., 2006a (Taxman et al., ,b, 2011 . Lentiviral shRNA vectors for gene silencing of RIPK2 and GFP were from the TRC Collection (Open Biosystems, Lafayette, CO, USA). Lentivirus was packaged in 293T cells with vectors pMD2.G and psPAX2 (Addgene plasmids 12259 and 12260, Cambridge, MA, USA). Cells were selected in 1 μg/mL puromycin for 2 wks, and JRed marker expression was confirmed by FACS. Bacterial infections (10 6 cells/mL in 10% FCS) were at 10 MOI unless otherwise indicated. Where indicated, cells were pretreated for 1 hr with DMSO solvent control (Sigma-Aldrich, St. Louis, MO, USA), 10 μg/mL Anakinra/Kineret ® (Amgen, Thousand Oaks, CA, USA), 10 μM YVAD-cmk (Clontech, Mountain View, CA, USA), 10 μM U0126 (Promega Corporation, Madison, WI, USA), 1-10 μM PP2, SB202190, or SB203580 (LC Laboratories, Woburn, MA, USA).
Patient Information
Demographic information for the 17 participants included in the microarray studies and 30 participants included in the real-time PCR analyses are detailed in the Results section. The study was approved by the Institutional Review Board of the University of North Carolina at Chapel Hill. Subjects were excluded if they:
(1) used either antibiotics or non-steroidal anti-inflammatory medications within 1 mo of the periodontal treatment; or (2) had a medical history significant for systemic diseases and were actively participating in the treatment thereof. Periodontal evaluation included probing depths, clinical attachment level, and bleeding on probing at 6 sites per tooth. Gingival tissue was sampled at the interproximal region. Specimens were treated with RNAlater (Qiagen, Valencia, CA, USA) overnight at 4ºC and stored at -80ºC.
Microarray Analysis
Microarray analysis of triplicate samples of Pg-infected shC-TRL and shASC#1 THP1 cells was performed at the Duke Microarray facility with 34,000 spot custom chips based on the version 3 Human oligo set (Operon Biotechnologies, Inc., Huntsville, AL, USA), and has been described previously (Taxman et al., 2011) . Microarray analyses of gingival biopsies of the 17 individual study participants were performed individually with the GeneChip ® Human Gene 1.0 ST Array covering 28,869 genes (Affymetrix, Santa Clara, CA, USA). Scanning was performed with the GeneChip Scanner 3000 7G platform (Affymetrix, Santa Clara, CA, USA). Gene expression was analyzed in GeneSpring 11 for interpretation of fold changes and statistical validation.
real-time Pcr
ASC mRNA levels were quantified with Taqman Assays on Demand ® (Applied Biosystems, Carlsbad, CA, USA). COX-2 and RIP2 mRNA were measured by SYBR-based quantitative real-time PCR as described previously (Taxman et al., 2006a,b) . The primer sequences were as follows: COX-2-GCCTGCT TGTCTGGAACAAC; TGGTGCCTGGTCTGATGATG; RIP2-CTGGCACTGTGTCGTCCGCC;TCTTTCACTGTCGAGCA GCGGAG, 18s-CGGCTACCACATCCAAGG; and GCTG CTGGCACCAGACTT. All values were standardized to 18s rRNA expression.
Western blot Analysis
Western blot analysis was performed as described previously (Taxman et al., 2006b) 
rEsults
Asc regulates COX-2 Expression and PGE 2 Production in thP1 Monocytic cells following Infection with Pg Monocytes are one of the primary contributors of cytokines and chemokines in periodontal degeneration (Page, 1992) . We have established the THP1 monocytic cell line as a useful model to study the interaction between the host and Pg infection (Taxman et al., 2006b (Taxman et al., , 2011 Huang et al., 2009) . To directly assess the function of ASC in regulating PGE 2 production, we constructed THP1 cell lines with reduced ASC expression using 2 different short hairpin RNAs: shRNA#1 (> 90% knockdown) and shASC#2 (~70% knockdown; Taxman et al., 2006a) . Levels of COX-2 mRNA and secreted PGE 2 were significantly reduced following Pg infection in both of the ASC knockdown cell lines as compared with either non-transduced cells (THP1) or cells bearing an empty vector (shCTRL) (Figs. 1A, 1B) .
ASC is known as an adaptor in the inflammasome complex, which is critical in the processing of IL-1β following pathogenic or environmental challenges (Broz and Monack, 2011) . To test whether IL-1β signaling is required for the induction of PGE 2 , we pre-treated THP1 cells with the IL-1β receptor antagonist Kineret ® at a dose shown to obliterate signaling (Taxman et al., 2006b) . Induction of PGE 2 was unaffected by Kineret ® , suggesting that PGE 2 induction is IL-1β-independent (Fig. 1C ). PGE 2 induction was also unaffected by YVAD-cmk, a specific inhibitor of caspase-1, the activation of which is absolutely required for IL-1β maturation in THP1 cells following infection with Pg (Taxman et al., 2006b; Huang et al., 2009) .
We and others recently demonstrated that ASC mediates the activation of MAPK independent of the inflammasome (Hasegawa et al., 2009; Taxman et al., 2011) . Therefore, we postulated that the ASC-dependent activation of PGE 2 may be regulated by MAPK activity. To test this possibility, we treated THP1 cells with U0126, an inhibitor of the ERK pathway, prior to infection with Pg (Fig. 1C, last lane) . U0126 nearly abolished PGE 2 protein production. Collectively, these results suggest that ASC is essential for Pg-induced PGE 2 production, and that its function in activating PGE 2 involves MAPK activation independent of its role in the inflammasome.
Asc Modulates the Expression of the MAP Kinase kinase kinase rIPK2
Homotypic CARD:CARD associations are essential for a host of inflammatory signaling cascades (Bouchier-Hayes and Martin, 2004) . A search for CARD-containing proteins with signaling activity upstream of the MAPKs led us to consider a possible role for RIPK2 in PGE 2 regulation. RIPK2 directly associates with ASC upon activation with LPS (Sarkar et al., 2006) . As one of the primary pathogens that triggers periodontal inflammation and tissue degeneration, Pg potently induced RIPK2 protein expression (Fig 2A) . Furthermore, repression of ASC strongly mitigated this induction (Fig. 2B) . To assess the specificity of this repression for RIPK2, we performed microarray analysis using RNA from Pg-infected shCTRL and shASC THP1 cells. RIPK2 expression was reduced 2.4-fold in Pginfected ASC knockdown cells (p value = 1.092 × 10 -4 ; corrected p value = 3.276 × 10 -4 ) (Fig. 2C) , whereas 2 other members of the RIPK family of MAPK-activating proteins (Meylan and Tschopp, 2005) , RIPK1 and RIPK3, were minimally changed.
ASC and RIPK2 Expression Is reduced in Gingival tissues from Individuals with chronic Periodontitis
We performed microarray analysis to assess whether levels of RIPK2 may be regulated in vivo. RNA was collected from gingival biopsies from seven patients with chronic adult periodontitis and ten healthy control individuals (Appendix Fig.) . Similar to our findings from Pg-infected THP1 ASC knockdown cells (Fig. 2C) , RIPK2 was reduced 1.5fold in chronic periodontitis gingival tissue (p value = 0.0108; corrected p value = 0.0324), while RIPK1 and RIPK3 showed minimal change (Fig. 2D ).
To verify these findings, we recruited 17 chronic periodontitis patients and 13 healthy volunteers. Patients and control individuals were age-matched (p > 0.1). Those with chronic periodontitis demonstrated marked increases in probing depth, clinical attachment loss, and bone loss as compared with healthy control individuals (Fig. 3A) . Consistent with our previous study (Zhang et al., 2011) , COX-2 expression was repressed in chronically inflamed gingival tissue (Fig. 3B ). Furthermore, ASC and RIPK2 were also reduced. These findings are consistent with a potential role for ASC in modulating RIPK2 expression both in vitro and in vivo.
rIPK2 Is required for MAPK Activation and PGE 2 Induction by Pg
We utilized two approaches to determine directly whether RIPK2 regulates PGE 2 induction. First, THP1 cells were treated with a panel of pharmacological agents known to inhibit RIPK2 kinase function (Bain et al., 2007) prior to infection with Pg. A dose-dependent reduction in PGE 2 was observed for each of these inhibitors (Fig. 4A) . Second, RIPK2 expression was inhibited by RNAi-mediated gene silencing. The activation of the MAPKs, ERK, and JNK in RIPK2-deficient cells was markedly reduced, verifying the role of RIPK2 as an upstream activator of these signaling molecules ( Fig 4B) . RIPK2 gene silencing also led to the reduced production of PGE 2 following infection with Pg at 2 different MOIs ( Fig 4C) . The findings collectively demonstrate that RIPK2 mediates PGE 2 production in response to a pathogen mediating periodontal destruction.
DIscussIOn
The progression of chronic adult periodontitis is featured by cycles of exacerbation and remission, eventually leading to irreversible periodontal structure destruction. A key to the development of novel treatment is the identification of critical inflammatory mediators that are regulated during these cycles and targeting of these mediators with small bioactive pharmacologic molecules. Initial studies suggested that the up-regulation of PGE 2 is associated with bone loss in humans and in animal models and that COX-2 inhibitors may reduce bone loss (Offenbacher et al., 1993; Noguchi and Ishikawa, 2007) . However, the ligature-induced periodontitis model features rapidly progressing periodontal inflammation, which more aptly reflects disease exacerbation, but not remission stages associated with human chronic adult periodontitis. In addition, for affected individuals, shallow sites are more likely to be responsible for the progression of periodontitis, whereas deep sites display lower levels of PGE 2 (Beck et al., 1997) . Indeed, previous studies have suggested that COX-2 levels are lower in chronically inflamed gingival tissue (Zhong et al., 2007; Zhang et al., 2011) .
The regulation of COX-2 is dependent upon both genetic and epigenetic mechanisms. In addition to a hypermethylation pattern at the COX-2 promoter region that dampens the production of COX-2 mRNA (Zhang et al., 2011) , the present study identified a novel mechanism controlling the production of PGE 2 that could have relevance in the pathogenesis of periodontitis (Fig.  4D) . When a periodontal pathogen such as Pg engages the host monocytic cells, ASC translates the insult into MAPK activation in a RIPK2-dependent fashion. Despite the high structural similarity among RIPKs, our study suggested a specificity of RIPK2 in mediating the inflammatory responses of periodontal tissue. Recent evidence reveals a central role of RIPK2 in mediating innate immune activation through association with NOD2 (Tigno-Aranjuez et al., 2010) . NOD2 is an NLR (nucleotidebinding, leucine-rich repeats) protein that is associated with Crohn's and other chronic auto-inflammatory diseases (Borzutzky et al., 2010) . Notably, NOD2 has also been reported to have a critical role in the sensing of periodontal pathogens (Okugawa et al., 2009) .
The pattern of ASC-mediated, RIPK2-dependent PGE2 production in THP-1 cells in response to Pg challenge in our study conceptually agrees with that observed in gingival tissues from patients with chronic adult periodontitis. The establishment of chronic periodontitis, however, is the cumulative outcome of the interaction between the host and multiple pathogens; thus, we chose Pg as a simplified model pathogen to highlight the significance of the ASC-RIPK2 axis. Consistent with our findings, a prior study showed reduced ASC levels upon Pg infection in Mono-Mac-6, a monocytic cell line (Bostanci et al., 2009) ; however, in the same study, differences were not observed in ASC in healthy vs. diseased gingival tissues. Given that PGE 2 is differentially regulated during disease remission/exacerbation (Zhong et al., 2007; Zhang et al., 2011) , differences in disease stage could explain this discrepancy between our studies. In addition, the expression profiles of apoptotic and inflammatory signaling genes for gingival tissues are known to be highly age-dependent (Gonzalez et al., 2011) . Finally, differences in the timing of biopsies, i.e., before or after non-surgical periodontal treatment, could contribute to the observed discrepancy. It is widely known that microarray can squelch differences between samples; however, our results were additionally verified by real-time PCR. Future study is necessary to delineate the role of RIPK2 in the progression stage of periodontitis development and to evaluate whether RIPK2 inhibitors might prevent chronic disease progression by stabilizing PGE 2 levels during periods of exacerbation.
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